BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 36834692)

  • 1. IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?
    Conserva MR; Redavid I; Anelli L; Zagaria A; Tarantini F; Cumbo C; Tota G; Parciante E; Coccaro N; Minervini CF; Minervini A; Specchia G; Musto P; Albano F
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - the role of Ikaros.
    Wang H; Ouyang H; Lai L; Petrovic-Dovat L; Stankov K; Bogdanovic G; Dovat S
    J BUON; 2014; 19(1):22-8. PubMed ID: 24659638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia.
    Dhanyamraju PK; Iyer S; Smink G; Bamme Y; Bhadauria P; Payne JL; Dovat E; Klink M; Ding Y
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
    Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
    Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ikaros and tumor suppression in acute lymphoblastic leukemia.
    Payne KJ; Dovat S
    Crit Rev Oncog; 2011; 16(1-2):3-12. PubMed ID: 22150303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature.
    Ruiz-Delgado GJ; Cantero-Fortiz Y; León-Peña AA; León-González M; Nuñez-Cortés AK; Ruiz-Argüelles GJ
    Rev Invest Clin; 2016; 68(4):210-4. PubMed ID: 27623040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia.
    Marke R; van Leeuwen FN; Scheijen B
    Haematologica; 2018 Apr; 103(4):565-574. PubMed ID: 29519871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance.
    Vitanza NA; Zaky W; Blum R; Meyer JA; Wang J; Bhatla T; Morrison DJ; Raetz EA; Carroll WL
    Pediatr Blood Cancer; 2014 Oct; 61(10):1779-85. PubMed ID: 24976218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IKZF1 alterations in acute lymphoblastic leukemia: The good, the bad and the ugly.
    Vairy S; Tran TH
    Blood Rev; 2020 Nov; 44():100677. PubMed ID: 32245541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia.
    Ge Z; Guo X; Li J; Hartman M; Kawasawa YI; Dovat S; Song C
    Oncotarget; 2015 Dec; 6(39):42300-11. PubMed ID: 26517351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement.
    Ge Z; Gu Y; Zhao G; Li J; Chen B; Han Q; Guo X; Liu J; Li H; Yu MD; Olson J; Steffens S; Payne KJ; Song C; Dovat S
    Oncotarget; 2016 Aug; 7(31):49722-49732. PubMed ID: 27391346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Ikaros family splicing variants in human hematopoietic lineages.
    Matulić M; Paradzik M; Puskarić BJ; Stipić J; Antica M
    Coll Antropol; 2010 Mar; 34(1):59-62. PubMed ID: 20432734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).
    Iacobucci I; Storlazzi CT; Cilloni D; Lonetti A; Ottaviani E; Soverini S; Astolfi A; Chiaretti S; Vitale A; Messa F; Impera L; Baldazzi C; D'Addabbo P; Papayannidis C; Lonoce A; Colarossi S; Vignetti M; Piccaluga PP; Paolini S; Russo D; Pane F; Saglio G; Baccarani M; Foà R; Martinelli G
    Blood; 2009 Sep; 114(10):2159-67. PubMed ID: 19589926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan.
    Asai D; Imamura T; Suenobu S; Saito A; Hasegawa D; Deguchi T; Hashii Y; Matsumoto K; Kawasaki H; Hori H; Iguchi A; Kosaka Y; Kato K; Horibe K; Yumura-Yagi K; Hara J; Oda M;
    Cancer Med; 2013 Jun; 2(3):412-9. PubMed ID: 23930217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.
    Gowda C; Song C; Kapadia M; Payne JL; Hu T; Ding Y; Dovat S
    Adv Biol Regul; 2017 Jan; 63():71-80. PubMed ID: 27666503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of Ikaros in B Cell Acute Lymphoblastic Leukemia].
    Zhang HY; Bai H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1194-8. PubMed ID: 26314472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia.
    Ge Z; Zhou X; Gu Y; Han Q; Li J; Chen B; Ge Q; Dovat E; Payne JL; Sun T; Song C; Dovat S
    Oncotarget; 2017 Jan; 8(5):8022-8034. PubMed ID: 28030830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ikaros family zinc-finger 1 mutation is an independent factor for the poor prognosis of adult B-cell acute lymphoblastic leukemia, and allogeneic hematopoietic stem cell transplantation can improve clinical outcomes.
    Tang S; Shen H; Qu C; Dai H; Zhu X; Xue S; Ding Z; Lu J; Wu D; Tang X
    Bone Marrow Transplant; 2019 Feb; 54(2):236-243. PubMed ID: 29942002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia.
    Song C; Ge Z; Ding Y; Tan BH; Desai D; Gowda K; Amin S; Gowda R; Robertson GP; Yue F; Huang S; Spiegelman V; Payne JL; Reeves ME; Gurel Z; Iyer S; Dhanyamraju PK; Xiang M; Kawasawa YI; Cury NM; Yunes JA; McGrath M; Schramm J; Su R; Yang Y; Zhao Z; Lyu X; Muschen M; Payne KJ; Gowda C; Dovat S
    Blood; 2020 Sep; 136(13):1520-1534. PubMed ID: 32396934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plant homeodomain finger protein 2 as a novel IKAROS target in acute lymphoblastic leukemia.
    Ge Z; Gu Y; Han Q; Sloane J; Ge Q; Gao G; Ma J; Song H; Hu J; Chen B; Dovat S; Song C
    Epigenomics; 2018 Jan; 10(1):59-69. PubMed ID: 28994305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.